← Back to Analyst Consensus 
STRO Buy
SUTRO BIOPHARMA, INC.
Current Price —
Implied Upside —
Analysts 20
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 15, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Aug 13, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Aug 13, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| May 28, 2026 | Barclays | initiate | — → Overweight | — | 53% |
| May 15, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| May 15, 2026 | Wedbush | upgrade | Neutral → Outperform | — | 58% |
| May 15, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 30, 2026 | Mizuho | initiate | — → Outperform | — | 52% |
| Apr 23, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Apr 17, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Apr 7, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| Mar 25, 2026 | Deutsche Bank | maintain | Buy → Buy | — | 57% |
| Mar 24, 2026 | Wells Fargo | upgrade | Equal-Weight → Overweight | — | 54% |
| Mar 24, 2026 | HC Wainwright & Co. | upgrade | Neutral → Buy | — | 44% |
| Jan 20, 2026 | Citizens | upgrade | Market Perform → Market Outperform | $23 | 47% |
| Dec 22, 2025 | HC Wainwright & Co. | maintain | Neutral → Neutral | $10 | 44% |
| Aug 12, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $3 | 54% |
| Jun 16, 2025 | Piper Sandler | upgrade | Neutral → Overweight | $2 | 54% |
| May 19, 2025 | B of A Securities | maintain | Underperform → Underperform | $0.8 | 53% |
| Apr 29, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $2 | 44% |
| Mar 17, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $2 | 44% |
| Mar 14, 2025 | Citizens Capital Markets | downgrade | Market Outperform → Market Perform | $0 | 49% |
| Mar 14, 2025 | Wedbush | downgrade | Outperform → Neutral | $2 | 58% |
| Mar 14, 2025 | B of A Securities | downgrade | Buy → Underperform | $1 | 53% |
| Dec 11, 2024 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $4 | 54% |
| Dec 11, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $17 | 53% |
| Nov 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Oct 11, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $11 | 54% |
| Oct 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Sep 16, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $17 | 53% |
| Sep 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Aug 16, 2024 | Truist Securities | maintain | Buy → Buy | $15 | 54% |
| Aug 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| May 15, 2024 | Oppenheimer | maintain | Outperform → Outperform | $10 | 52% |
| May 14, 2024 | Wedbush | reiterate | Outperform → Outperform | $8 | 58% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| May 8, 2024 | B of A Securities | initiate | — → Buy | $12 | 53% |
| Apr 3, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $11 | 54% |
| Apr 3, 2024 | Oppenheimer | maintain | Outperform → Outperform | $10 | 52% |
| Apr 3, 2024 | Truist Securities | maintain | Buy → Buy | $18 | 54% |
| Apr 3, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $17 | 53% |
| Mar 28, 2024 | Oppenheimer | maintain | Outperform → Outperform | $10 | 52% |
| Mar 27, 2024 | Oppenheimer | maintain | Outperform → Outperform | $10 | 52% |
| Mar 26, 2024 | Wedbush | maintain | Outperform → Outperform | $8 | 58% |
| Mar 26, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $17 | 53% |
| Mar 26, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Nov 15, 2023 | Piper Sandler | maintain | Overweight → Overweight | $12 | 54% |
| Nov 14, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Nov 9, 2023 | Deutsche Bank | initiate | — → Buy | $12 | 57% |
| Oct 23, 2023 | Wedbush | reiterate | Outperform → Outperform | $12 | 58% |
Price Target Trend
Apr 19, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days